Pricing & Reimbursement
Our vision is that all patients with chronic and/or lifelong conditions in the EU have access to high quality, patient-centred equitable health and social care. There is an urgent need to identify effective and concrete actions at EU level to close the current gap on health inequalities, so that all patients across Europe have access to high-quality, affordable treatments.
EPF statement on the pricing and reimbursement of innovative medicines. The paper outlines the 9 core principles from the patients' perspective on the value and pricing of innovative medicines. The statement can be consulted here.
Contact: Kaisa Immonen, Director of Policy.